Interventional Oncology Devices | Market Insights | Asia Pacific (Supplemental) | 2021
Although the Asia Pacific market for interventional oncology devices will be hindered in the immediate term by the impact of theCOVID-19pandemic, the market will expand rapidlythrough 2029, driven primarily bycontinued growth of cancer incidence, improving access to treatment, adoption of premium-priced devices, and the introduction of new devices in the countries covered.
This Medtech 360 Reportprovides high-level market metrics for interventional oncologydevices in the Asia Pacific region,including country-level data for major countries and aggregate data for the rest of Asia Pacific,across a 10-year period.
